PCCA’s founders have played key roles in the development of over half of the nation’s Proton Beam Therapy centers.

Proton Therapy is a highly advanced and very specific form of radiation therapy that uses protons, patient from hydrogen atoms, once they have been stripped of their electrons and are then accelerated in a large particle accelerator, to precisely target cancerous tumors, throughout the body. Proton Therapy is a proven (FDA Cleared and Medicare Reimbursed) outpatient therapy and has effectively been used to treat over 60,000 cancer patients, worldwide, since the mid 1960’s. A proton center can successfully treat as many as 2,000 cancer patients, annually. Proton Therapy provides patients with the highest attainable control rates (as high as 90%) with the least amount of side effects, compared to surgery, chemotherapy, or conventional radiation therapy alternatives.

PCCA’s founders have played key roles in patient marketing, staffing, training, and leading the operations of the world’s first hospital-based high-throughput proton therapy center, at Loma Linda University Medical Center. Over the past ten years, PCCA’s founders have also played key roles and have assisted several healthcare systems that have opened proton centers in the U.S., as well as several abroad. Over this time, PCCA has identified and refined the opportunities for improvement in all aspects of project development. PCCA is uniquely qualified to reduce the overall development time to construct a center by spearheading all aspects of development; including but not limited to negotiations, funding, patient marketing, facility management, project management, and clinical operations.